💊
İlaç Sektörü Hisseleri
İlaç Sektörü altında 513 Hisse Senedi
İlaç sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$42.3B
Toplam Piyasa Değeri
İlaç Sektörü Hisseleri
Sayfa 3/6 (Toplam: 513)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | $724.90M | $4.28 | 1.42% |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | $719.65M | $9.86 | 2.39% |
| IKNA | Ikena Oncology, Inc. | $718.82M | $17.16 | 1152.55% |
| VTYX | Ventyx Biosciences, Inc. | $713.23M | $9.99 | 0.05% |
| KROS | Keros Therapeutics, Inc. | $708.61M | $17.48 | 0.11% |
| GYRE | Gyre Therapeutics, Inc. | $704.05M | $7.75 | 1.27% |
| OMER | Omeros Corporation | $686.96M | $9.69 | 0.62% |
| CRVS | Corvus Pharmaceuticals, Inc. | $684.51M | $9.17 | 1.10% |
| RGNX | REGENXBIO Inc. | $677.79M | $13.39 | 0.98% |
| PRME | Prime Medicine, Inc. | $676.15M | $3.82 | 2.96% |
| CGEM | Cullinan Oncology, Inc. | $671.69M | $11.37 | 3.15% |
| MGTX | MeiraGTx Holdings plc | $668.07M | $8.30 | 1.22% |
| ORGO | Organogenesis Holdings Inc. | $657.40M | $5.18 | 4.43% |
| VSTM | Verastem, Inc. | $644.13M | $10.64 | 0.09% |
| PROK | ProKidney Corp. | $624.73M | $2.22 | 4.72% |
| AQST | Aquestive Therapeutics, Inc. | $614.71M | $6.19 | 0.48% |
| SRDX | Surmodics, Inc. | $614.51M | $42.98 | 0.35% |
| EBS | Emergent BioSolutions Inc. | $602.90M | $11.17 | 1.09% |
| FULC | Fulcrum Therapeutics, Inc. | $591.98M | $10.94 | 3.36% |
| MNPR | Monopar Therapeutics Inc. | $575.91M | $86.18 | 1.35% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $569.38M | $3.50 | 9.33% |
| RGLS | Regulus Therapeutics Inc. | $564.95M | $8.16 | 0.00% |
| RAPT | RAPT Therapeutics, Inc. | $558.97M | $33.80 | 1.62% |
| SAGE | Sage Therapeutics, Inc. | $544.94M | $8.68 | 0.00% |
| FDMT | 4D Molecular Therapeutics, Inc. | $544.55M | $11.66 | 6.10% |
| NAGE | Niagen Bioscience Inc | $540.29M | $6.77 | 1.74% |
| ANNX | Annexon, Inc. | $538.18M | $4.50 | 4.17% |
| ZIMV | ZimVie Inc. | $535.63M | $18.99 | 0.00% |
| DSGN | Design Therapeutics, Inc. | $534.86M | $9.39 | 0.21% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $519.66M | $1.43 | 0.00% |
| LYEL | Lyell Immunopharma, Inc. | $509.23M | $24.00 | 1.68% |
| DRUG | Bright Minds Biosciences Inc. | $495.95M | $70.00 | 5.80% |
| CYRX | Cryoport, Inc. | $481.64M | $9.62 | 0.21% |
| VREX | Varex Imaging Corporation | $479.00M | $11.57 | 0.00% |
| ABSI | Absci Corporation | $478.18M | $3.18 | 2.91% |
| ZVRA | Zevra Therapeutics, Inc. | $474.57M | $8.43 | 1.98% |
| ALT | Altimmune, Inc. | $464.23M | $5.26 | 1.74% |
| EOLS | Evolus, Inc. | $464.11M | $7.16 | 1.70% |
| ITOS | iTeos Therapeutics, Inc. | $448.68M | $10.15 | 0.20% |
| PEPG | PepGen Inc. | $443.02M | $6.45 | 5.83% |
| SIGA | SIGA Technologies, Inc. | $433.96M | $6.06 | 0.33% |
| ANRO | Alto Neuroscience, Inc. | $430.27M | $13.85 | 2.52% |
| SLDB | Solid Biosciences Inc. | $423.05M | $5.43 | 1.31% |
| AKBA | Akebia Therapeutics, Inc. | $419.28M | $1.58 | 0.63% |
| AURA | Aura Biosciences, Inc. | $419.11M | $6.60 | 3.45% |
| PRTC | PureTech Health plc | $403.61M | $16.70 | 4.38% |
| LCTX | Lineage Cell Therapeutics, Inc. | $401.41M | $1.75 | 2.05% |
| TECX | Tectonic Therapeutic, Inc. | $401.28M | $21.44 | 0.23% |
| TRDA | Entrada Therapeutics, Inc. | $392.51M | $10.27 | 1.88% |
| YMAB | Y-mAbs Therapeutics, Inc. | $391.22M | $8.61 | 0.23% |
| OCGN | Ocugen, Inc. | $387.28M | $1.24 | 5.08% |
| XOMA | XOMA Corporation | $385.41M | $32.13 | 0.50% |
| VIGL | Vigil Neuroscience, Inc. | $375.71M | $8.05 | 0.00% |
| NMRA | Neumora Therapeutics, Inc. Common Stock | $374.11M | $2.24 | 2.18% |
| RCKT | Rocket Pharmaceuticals, Inc. | $371.74M | $3.44 | 4.41% |
| GALT | Galectin Therapeutics Inc. | $368.93M | $5.73 | 0.52% |
| AVXL | Anavex Life Sciences Corp. | $342.20M | $3.83 | 0.78% |
| SLP | Simulations Plus, Inc. | $342.16M | $17.00 | 1.68% |
| BIOA | BioAge Labs, Inc. | $340.26M | $9.49 | 1.50% |
| BNTC | Benitec Biopharma Inc. | $340.16M | $12.96 | 0.42% |
| KYTX | Kyverna Therapeutics, Inc. | $335.88M | $7.67 | 0.13% |
| VRNOF | Verano Holdings Corp. | $332.83M | $0.92 | 5.74% |
| RLMD | Relmada Therapeutics, Inc. | $330.73M | $4.51 | 7.64% |
| ALDX | Aldeyra Therapeutics, Inc. | $329.58M | $5.48 | 1.97% |
| ALLO | Allogene Therapeutics, Inc. | $328.11M | $1.46 | 2.82% |
| NGNE | Neurogene Inc. | $326.52M | $21.08 | 0.43% |
| PYXS | Pyxis Oncology, Inc. | $323.08M | $5.19 | 1.70% |
| CTNM | Contineum Therapeutics, Inc. Class A Common Stock | $323.03M | $11.07 | 2.88% |
| IVVD | Invivyd, Inc. | $322.53M | $2.43 | 4.29% |
| VNDA | Vanda Pharmaceuticals Inc. | $316.74M | $5.36 | 1.13% |
| TOI | The Oncology Institute, Inc. | $310.39M | $3.15 | 1.12% |
| ACRS | Aclaris Therapeutics, Inc. | $306.62M | $2.83 | 1.74% |
| LRMR | Larimar Therapeutics, Inc. | $302.99M | $3.54 | 0.28% |
| SCPH | scPharmaceuticals Inc. | $302.20M | $5.67 | 0.00% |
| ENTA | Enanta Pharmaceuticals, Inc. | $301.23M | $14.12 | 1.29% |
| OBIO | Orchestra BioMed Holdings, Inc. | $300.39M | $5.32 | 1.53% |
| LFCR | Lifecore Biomedical, Inc. | $295.56M | $7.90 | 0.89% |
| TARA | Protara Therapeutics, Inc. | $284.77M | $7.38 | 0.34% |
| OPRX | OptimizeRx Corporation | $282.41M | $15.27 | 0.72% |
| IMRX | Immuneering Corporation | $278.08M | $7.66 | 2.00% |
| VMD | Viemed Healthcare, Inc. | $269.79M | $6.91 | 0.44% |
| FHTX | Foghorn Therapeutics Inc. | $268.61M | $4.75 | 1.25% |
| ARMP | Armata Pharmaceuticals, Inc. | $266.30M | $7.33 | 1.52% |
| TSVT | 2seventy bio, Inc. | $266.14M | $5.00 | 0.00% |
| INZY | Inozyme Pharma, Inc. | $258.25M | $4.00 | 0.25% |
| PBYI | Puma Biotechnology, Inc. | $253.97M | $5.04 | 0.20% |
| ABEO | Abeona Therapeutics Inc. | $253.50M | $5.07 | 1.55% |
| ZURA | Zura Bio Limited | $249.68M | $3.84 | 1.05% |
| CABA | Cabaletta Bio, Inc. | $247.40M | $2.57 | 8.44% |
| CAPR | Capricor Therapeutics, Inc. | $244.59M | $5.35 | 3.08% |
| THRD | Third Harmonic Bio, Inc. | $242.79M | $5.38 | 0.09% |
| AVIR | Atea Pharmaceuticals, Inc. | $242.20M | $3.10 | 1.64% |
| TNYA | Tenaya Therapeutics, Inc. | $233.11M | $1.40 | 2.94% |
| SLRN | Acelyrin, Inc. | $229.17M | $2.27 | 0.00% |
| VYGR | Voyager Therapeutics, Inc. | $227.11M | $4.08 | 1.36% |
| TLSI | TriSalus Life Sciences, Inc. | $226.97M | $6.87 | 6.18% |
| SGMT | Sagimet Biosciences Inc. | $223.83M | $7.22 | 1.98% |
| CRGX | CARGO Therapeutics, Inc. Common Stock | $216.19M | $4.47 | 0.00% |
| GNLX | Genelux Corporation | $211.57M | $5.56 | 0.54% |
| OMI | Owens & Minor, Inc. | $210.16M | $2.72 | 1.09% |